DRKS00030508RecruitingNot Applicable
Registry for adults with congenital heart disease (ACHD) with abnormal ventricular function and/or heart failure - PATHFINDER-CHD
Deutsches Herzzentrum München0 sites1,500 target enrollmentStarted: November 21, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 99 Years (—)
- Sex
- All
Inclusion Criteria
- •Minimum age 18 years, patient at one of the participating centers, consent to participate in the study
Exclusion Criteria
- •Failure to meet inclusion criteria
Investigators
Similar Trials
Recruiting
Not Applicable
mHealth in grown-ups congenital heart diseaseAny congenital heart diseaseNL-OMON27137Amsterdam UMC, location AMC, Netherlands Heart Intitute196
Recruiting
Not Applicable
ational Register for Congenital Heart Defectsall types of congenital heart defects (Q20.0 - Q27.8)congenital arrhythmias (I45.6, I45.8, I47.2)I42.0 -I42.9)cardiomyopathies of childhood (I420 -I42.9)DRKS00031236RAHF e.V.300,000
Recruiting
Not Applicable
Investigation of Adults With Congenital Heart Disease in the Scope of the ICFCongenital Heart DiseaseICFQuality of LifeNCT05774158Hacettepe University30
Recruiting
Not Applicable
National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/ValsartanComplex Congenital Heart DiseaseNCT06149806University Hospital, Grenoble50
Completed
Not Applicable
Effect of Ketamine on Proinflammatory and Anti-inflammatory cytokine response in Pediatric cardiac surgery.congenital heart diseaseACTRN12615000468527Tamer Hamed Aly Ibrahim66